Justification NAICS 325412

Pylarify (F-18 Piflufolastat) Attachment 2: Request for Limited Sources Justification Format >SAT VHAPG Part 808.405-6 Limiting Sources Page 1 of 4 Revision: 01 Effective Date: 09/01/2024 Acquisition ID#: 36C250-25-AP-2686 LIMITED SOURCES JUSTIFICATION ORDER >SAT FAR PART 8.405-6 Acquisition Plan Action ID: 36C250-25-AP-2686 (1) Contracting Activity: Department of Veterans Affairs, Network Contracting Office 10, located at 5500 Armstrong Road, Battle Creek, MI 49037, in support of VISN 10 LTC Charles S. Kettles VA Medical Center at 2215 Fuller Road, Ann Arbor, MI 48105. 2237: 506-26-1-020-0001 (2) Description of Action: This acquisition is conducted under the authority of the Multiple-Award Schedule Program (41 U.S.C. 152(3) and 40 U.S.C. 501). New requirement for Pylarify radiopharmaceutical. Order against: FSS Contract Number: 36F79725D0093 (Expires March 31, 2030) Name of Proposed Contractor: Progenics Pharmaceuticals, Inc. Street Address: 331 Treble Cove Road City, State, Zip: N. Billerica, MA 01862 Phone: 414-336-9169 (3) Description of Supplies or Services: Nuclear Radioactive Drug Pylarify (F-18 Piflufolastat) A prostate cancer treatment drug. Nuclear Medicine is requesting ...

Notice ID: 8b47ef0e613a455087abd8726513306c · View on SAM.gov ↗